Science Explorer Interactive view Map
Company · Tübingen · Germany

CureVac (Germany)

curevac.comROR OpenAlex
Research works
67
▲ 16% vs 2013–17
Citations
5.3k
77.9 per fractional work
Top-10% rate
26.7%
record average 16.5%
Open access
64%
world 28%

Not ranked overall: CureVac (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.79× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.96× its world share, 5 worksBiochemistry, Geneti…Immunology and Microbiology: 20.58× its world share, 4 worksImmunology and Micro…Chemistry: 1.16× its world share, 0 worksChemistryComputer Science: 0.17× its world share, 0 worksComputer ScienceEngineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.07× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.52× its world share, 0 worksMaterials ScienceMathematics: 0.19× its world share, 0 worksMathematicsMedicine: 1.79× its world share, 6 worksMedicineEconomics, Econometrics and Finance: 0.11× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.09× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 20.6×. Every wedge is a field page.

Which keywords describe research at CureVac (Germany)?

By fractional works in all years, weighted toward what it does more of than the world: Gene Therapy, Immunity, Gene Silencing, RNA Interference, siRNA Delivery, Vaccine, Cancer Immunotherapy and Innate Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Therapy15▲ 83×4 topics
  2. Immunity12▲ 55×5 topics
  3. Epidemiology11▲ 4.0×21 topics
  4. Gene Silencing11▲ 132×2 topics
  5. RNA Interference11▲ 141×1 topic
  6. siRNA Delivery11▲ 210×1 topic
  7. Vaccine10▲ 39×9 topics
  8. Cancer Immunotherapy10▲ 106×2 topics
  9. Innate Immunity10▲ 41×3 topics
  10. Antigen Presentation9▲ 135×2 topics
  11. Dendritic Cells9▲ 115×1 topic
  12. Tumor Antigen9▲ 163×1 topic
  13. Pathogenesis8▲ 22×9 topics
  14. Immune Response6▲ 13×9 topics
  15. Coronavirus5▲ 66×2 topics
  16. Pandemic4▲ 14×5 topics
  17. SARS-CoV-24▲ 42×4 topics
  18. ACE2 Receptor4▲ 48×2 topics
  19. Inflammation4▲ 2.3×10 topics
  20. Genomic Integration3▲ 48×2 topics
  21. Viral Transmission3▲ 52×2 topics
  22. Pattern Recognition Receptors3▲ 34×2 topics
  23. AAV3▲ 73×1 topic
  24. Viral Vectors3▲ 73×1 topic
  25. Infection3▲ 16×3 topics
  26. Mutation3▲ 28×2 topics
  27. Pathogen Recognition3▲ 50×2 topics
  28. antibody3▲ 100×1 topic
  29. spike protein3▲ 100×1 topic
  30. Norovirus3▲ 75×1 topic
  31. Rotavirus3▲ 75×1 topic
  32. Innate Antiviral Responses3▲ 60×1 topic
  33. Metagenomics3▲ 33×2 topics
  34. Toll-like Receptors3▲ 24×1 topic
  35. Immunotherapy3▲ 6.0×9 topics
  36. Genomic Sequencing2▲ 25×2 topics
  37. Circovirus2▲ 92×1 topic
  38. Porcine Reproductive and Respiratory Syndrome Virus2▲ 92×1 topic
  39. Monoclonal Antibodies2▲ 20×2 topics
  40. Tumor Regression2▲ 31×2 topics

Which research topics does CureVac (Germany) publish most on?

By volume in 2022–2025: RNA Interference and Gene Delivery, SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses and Animal Virus Infections Studies.

RNA Interference and Gene Delivery: 2 fractional worksSARS-CoV-2 and COVID-19 Research: 2 fractional worksImmunotherapy and Immune Responses: 2 fractional worksAnimal Virus Infections Studies: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksCOVID-19 Clinical Resear…1COVID-19 Clinical Research Studies: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksViral gastroenteritis research and epidemiology: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
Molecular BiologyInfectious DiseasesImmunologyAnimal Science and Zoology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA Interference and Gene Delivery Molecular Biology 2 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 2 works
  3. 3 Immunotherapy and Immune Responses Immunology 2 works
  4. 4 Animal Virus Infections Studies Animal Science and Zoology 1 works
  5. 5 Biosimilars and Bioanalytical Methods Immunology 1 works
  6. 6 COVID-19 Clinical Research Studies Infectious Diseases 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Viral gastroenteritis research and epidemiology Infectious Diseases 0 works
  9. 9 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.5%not open35.5%

World: 28% of research is openly available.

with international co-authors30.6%domestic only69.4%

World: 19% is written across borders.

How has CureVac (Germany)'s research output changed?

Output in 2018–2022 was 16% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tübingen

All research institutions in Tübingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.